These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9495605)

  • 1. Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers.
    Bonaccorso S; Lin AH; Verkerk R; Van Hunsel F; Libbrecht I; Scharpé S; DeClerck L; Biondi M; Janca A; Maes M
    J Affect Disord; 1998 Feb; 48(1):75-82. PubMed ID: 9495605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of urinary neopterin and pseudouridine in patients with malignant proliferative diseases.
    Motyl T; Traczyk Z; Holska W; Daniewska-Michalska D; Cieśluk S; Kukulska W; Kałuzny Z; Podgurniak M
    Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):205-9. PubMed ID: 8318566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of biopterin and neopterin in psychiatric disorders.
    Duch DS; Woolf JH; Nichol CA; Davidson JR; Garbutt JC
    Psychiatry Res; 1984 Feb; 11(2):83-9. PubMed ID: 6584938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia.
    Maes M; Lin A; Bonaccorso S; van Hunsel F; Van Gastel A; Delmeire L; Biondi M; Bosmans E; Kenis G; Scharpé S
    Acta Psychiatr Scand; 1998 Oct; 98(4):328-35. PubMed ID: 9821456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia.
    Dunbar PR; Hill J; Neale TJ; Mellsop GW
    Psychol Med; 1992 Nov; 22(4):1051-7. PubMed ID: 1488478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
    Bennie EH; Mullin JM; Martindale JJ
    J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.
    Zanardi R; Franchini L; Gasperini M; Perez J; Smeraldi E
    Am J Psychiatry; 1996 Dec; 153(12):1631-3. PubMed ID: 8942464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB; Stahl SM; Hertzman M; Harrison WM
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response.
    Maes M; Scharpé S; Meltzer HY; Okayli G; Bosmans E; D'Hondt P; Vanden Bossche BV; Cosyns P
    Psychiatry Res; 1994 Nov; 54(2):143-60. PubMed ID: 7761549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder.
    Kline NA; Dow BM; Brown SA; Matloff JL
    Am J Psychiatry; 1994 Apr; 151(4):621. PubMed ID: 8147472
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of sertraline in the management of depression.
    Shelton RC
    Clin Ther; 1994; 16(5):768-82; discussion 767. PubMed ID: 7859236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline: a new antidepressant.
    Auster R
    Am Fam Physician; 1993 Aug; 48(2):311-4. PubMed ID: 8342482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.
    Aguglia E; Casacchia M; Cassano GB; Faravelli C; Ferrari G; Giordano P; Pancheri P; Ravizza L; Trabucchi M; Bolino F
    Int Clin Psychopharmacol; 1993; 8(3):197-202. PubMed ID: 8263318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice.
    Ekselius L; von Knorring L; Eberhard G
    Int Clin Psychopharmacol; 1997 Nov; 12(6):323-31. PubMed ID: 9547134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?
    Brown WA; Harrison W
    J Clin Psychiatry; 1995 Jan; 56(1):30-4. PubMed ID: 7836337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR; Jann MW
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of SSRI response.
    Salzman C
    Harv Rev Psychiatry; 1996; 4(4):215-7. PubMed ID: 9384996
    [No Abstract]   [Full Text] [Related]  

  • 18. Depression and tetrahydrobiopterin: the folate connection.
    Coppen A; Swade C; Jones SA; Armstrong RA; Blair JA; Leeming RJ
    J Affect Disord; 1989; 16(2-3):103-7. PubMed ID: 2522108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline and breast-feeding.
    Epperson CN; Anderson GM; McDougle CJ
    N Engl J Med; 1997 Apr; 336(16):1189-90. PubMed ID: 9102576
    [No Abstract]   [Full Text] [Related]  

  • 20. Lithium augmentation in sertraline-resistant depression: a preliminary dose-response study.
    Dinan TG
    Acta Psychiatr Scand; 1993 Oct; 88(4):300-1. PubMed ID: 8256650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.